Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
11/15/2005 | US6965017 Melanoma antigens and their use in diagnostic and therapeutic methods |
11/15/2005 | US6964978 Dissolving with crystal growth inihibitos; drying |
11/15/2005 | US6964976 Amino alcohol derivatives |
11/15/2005 | US6964971 Oral administering; sustained release |
11/15/2005 | US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use |
11/15/2005 | US6964965 Corticotropin releasing factor antagonists |
11/15/2005 | US6964962 A norepinephrine reuptake inhibitor or its salt and a neuroleptic agent |
11/15/2005 | US6964960 Indoloquinazolinones |
11/15/2005 | US6964956 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization |
11/15/2005 | US6964853 Smad6 and uses thereof |
11/15/2005 | US6964785 Herbal composition for improving anticancer activity, immune response and hematopoiesis of the body, and protecting the body from oxidative damage, and the method of preparing the same |
11/15/2005 | US6964784 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and dna repair processes of warm blooded animals |
11/15/2005 | US6964769 Molecular antigen array |
11/15/2005 | US6964766 Peptides for use in immunotherapy of autoimmune diseases |
11/10/2005 | WO2005105151A1 Pegylated thymosin 1 derivatives |
11/10/2005 | WO2004069142A8 Anti-candida agents for the treatment of prion diseases |
11/10/2005 | US20050250950 1,3-oxathiolane nucleoside analogues |
11/10/2005 | US20050250939 Process for the production of multiple cross-linked hyaluronic acid derivatives |
11/10/2005 | US20050250934 synthetic peptide conjugate compositions for the treatment of immunoglobulins (IgE)-mediated allergic diseases by active immunization |
11/10/2005 | US20050250848 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
11/10/2005 | US20050250846 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use |
11/10/2005 | US20050250796 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease |
11/10/2005 | US20050250792 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
11/10/2005 | US20050250790 Novel sulfonic acid derivatives |
11/10/2005 | US20050250760 1-[(Indol-3-yl)carbonyl]piperazine derivatives |
11/10/2005 | US20050250727 Use of immunomodulating agents |
11/10/2005 | US20050250723 Immunostimulation by chemically modified RNA |
11/10/2005 | US20050250716 Immunostimulatory oligodeoxynucleotides |
11/10/2005 | US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
11/10/2005 | US20050250698 Method for obtaining a TGF-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
11/10/2005 | US20050250697 Method for obtaining a TGF-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
11/10/2005 | US20050250196 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
11/10/2005 | US20050250175 Bacterial cell wall skeleton component preparaion |
11/10/2005 | US20050250120 Deleted sequences in M. bovis BCG/M bovis or M. tuberculosis, method for detecting mycobacteria using these sequences and vaccines |
11/10/2005 | US20050249756 Use of human prostate cell lines in cancer treatment |
11/10/2005 | US20050249722 Monoclonal antibodies with enhanced ADCC function |
11/10/2005 | US20050249714 Method of using secretin and compositions made therefrom for the treatment of autism and other neurological, behavioral and immunological disorders |
11/10/2005 | US20050249710 biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer comprising hydroxyaliphatic carboxylic acids, and polysaccharides |
11/10/2005 | US20050249707 Stimulating an immune response in human or animal, by administering a gene, infected DENDRITIC CELLS; without preventing antigen processing occurring within the infected cell; increase gene expression on the surface of tumour cells; protection against cancer; vaccines |
11/10/2005 | US20050249705 Inactivated herpes simplex virus glycoprotein for treating metastasis; ultraviolet radiation and heating; highly safe |
11/10/2005 | US20050249704 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
11/10/2005 | US20050249701 Il-7 Drug substance, composition, preparation and uses |
11/10/2005 | US20050249700 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
11/10/2005 | US20050249698 Synergistic effect of the osteogenic growth peptide and the granulocyte clony stimulating factor on haematogenesis |
11/10/2005 | DE10112926B4 Verwendung von Aminooxyacetat zur Tumorbehandlung Use of aminooxyacetate for tumor treatment |
11/10/2005 | CA2563569A1 Combinations comprising a s1p receptor agonist and a jak3 kinase inhibitor |
11/09/2005 | EP1593681A1 Tricyclic compound, process for producing the same, and use |
11/09/2005 | EP1593680A1 Fused-ring pyridine derivative, process for producing the same, and use |
11/09/2005 | EP1593673A1 Acrylamide derivative, process for producing the same, and use |
11/09/2005 | EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity |
11/09/2005 | EP1593393A2 Anti-TNF antibodies and methotrexate in the treatment of autoimmune diseases |
11/09/2005 | EP1593386A1 Use of galectin-2 |
11/09/2005 | EP1593383A1 Lotus plant extract with antihistaminic activity |
11/09/2005 | EP1593382A1 Use of probiotic lactic bacteria for balancing the skin's immune system |
11/09/2005 | EP1593379A2 Uses of PPAR-gamma agonists in neutrophil-induced diseases |
11/09/2005 | EP1592777A2 A method for generating high affinity antibodies |
11/09/2005 | EP1592776A2 HIGH AFFINITY ANTI-HUMAN IgE ANTIBODIES |
11/09/2005 | EP1592680A1 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors |
11/09/2005 | EP1592452A2 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
11/09/2005 | EP1592449A2 Sensitizing cells for apoptosis by selectively blocking cytokines |
11/09/2005 | EP1592384A2 Cop 1 for treatment of inflammatory bowel diseases |
11/09/2005 | EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
11/09/2005 | EP1405083B1 Natural ligand of gpcr chemr23 and uses thereof |
11/09/2005 | EP1297172B1 Methods for producing modified glycoproteins |
11/09/2005 | EP1287142B1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide |
11/09/2005 | EP1254118B1 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives |
11/09/2005 | EP1218376B1 Tyrosine kinase inhibitors |
11/09/2005 | EP1214325B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
11/09/2005 | EP1212421B1 Gas1 polypeptides |
11/09/2005 | EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
11/09/2005 | EP1202974B1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
11/09/2005 | EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents |
11/09/2005 | EP1144371B1 Benzenesulphonamide derivatives and their use as mek inhibitors |
11/09/2005 | EP1075519B1 Inhibitors of nf-kb activation |
11/09/2005 | EP1049700B1 Chemokine receptor antagonists and methods of use therefor |
11/09/2005 | EP1019089B1 Long-acting drugs and pharmaceutical compositions comprising them |
11/09/2005 | EP0808330B1 A process for preparing certain aza cyclohexapeptides |
11/09/2005 | CN1694900A EE3-protein family and corresponding DNA sequences |
11/09/2005 | CN1694894A Anti-IL-6 antibodies, compositions, methods and uses |
11/09/2005 | CN1694879A Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
11/09/2005 | CN1694875A 5-aryltetrazole compounds and uses thereof |
11/09/2005 | CN1694736A Medical devices containing rapamycin analogs |
11/09/2005 | CN1694722A A process for the preparation of a non-toxic anthrax vaccine |
11/09/2005 | CN1694719A Casein derived peptides and uses thereof in therapy |
11/09/2005 | CN1694703A Use of indolyl derivatives for the manufacture of a medicament for the treatment allergic rhinitis |
11/09/2005 | CN1694490A Method, equipment and computer program of changed digital color image |
11/09/2005 | CN1226290C Ligands of nuclear receptor |
11/09/2005 | CN1226044C Oral liquid for relieving rheumatic pains and stopping itch, and its preparation method |
11/08/2005 | US6963012 2-amino-2-[4-(3-benzyloxyphenoxy)-2-chlorophenyl]propyl-1,3-propanediol for example; treating autoimmune diseases such as rheumatoid arthritis, transplant rejection, psoriasis, dermatitis |
11/08/2005 | US6963011 Central nervous system disorders; psychological disorders |
11/08/2005 | US6963010 Hydrophobic polyamine analogs and methods for their use |
11/08/2005 | US6962996 Inhibitors of p38 |
11/08/2005 | US6962993 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3 |
11/08/2005 | US6962978 Multiple sclerosis; immobilization; water solubility |
11/08/2005 | US6962972 Active material; denaturing protein; hybrid enzyme |
11/08/2005 | US6962941 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis |
11/08/2005 | US6962937 Imidazolidine derivatives, their preparation and their use |
11/08/2005 | US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis, |
11/08/2005 | US6962933 cerebral hemorrhage/infarction, head trauma, spinal cord injury, brain edema, multiple sclerosis, Alzheimer's/Parkinson's disease, amyotrophic lateral sclerosis, diabetes, osteoporosis, Creutzfeldt-Jakob disease or virus infections |
11/08/2005 | US6962924 Antihistamines; side effect reduction |